Mayo Clinic does not own, operate, or staff Bali International Hospital (BIH). What is confirmed, and clarified publicly by Mayo Clinic itself, is a consulting agreement: Mayo advises BIH’s state-owned operator on facility design, governance and culture, medical services, quality assurance, and academic development. BIH is an Indonesian government asset developed by IHC (Pertamedika), the state hospital holding company, and anchors KEK Sanur, Indonesia’s first healthcare Special Economic Zone, inaugurated by President Prabowo in June 2025.
Marketing around Sanur often compresses “Mayo-advised” into “Mayo Clinic hospital.” Those are different assets. The honest version is still substantial: a benchmarked anchor hospital, a widening roster of clinical operators, and rules built to keep Indonesian medical spending onshore. This guide separates the verified record from the embellishment, then looks at what that credibility layer means for the assets around it.
What the Mayo agreement covers
Announced in 2022, while the hospital was under construction on the former Grand Inna Bali Beach site, the collaboration is advisory across five areas: facility design, governance and culture, medical services (particularly BIH’s centres of excellence), quality assurance, and clinician training. Mayo has been explicit that it plays no part in day-to-day operations: a bounded consulting engagement of the kind it provides to hospital systems worldwide, valuable for standards, not an operating commitment or a franchise.
What the Mayo name does not mean
Several claims in listings and brochures are simply wrong: BIH is not a Mayo Clinic branch, Mayo holds no equity in the hospital or the zone, and no arrangement places Mayo physicians permanently on Sanur’s staff. Treatment at BIH is not treatment at Mayo Clinic in the United States. A brochure implying Mayo ownership is a red flag about the seller’s accuracy on everything else; the consulting relationship is a strong signal on its own merits and needs no inflating.
The hospital that has actually been built
Strip away the branding question and the asset is considerable: a Class A facility with 255 beds, intensive-care units, operating theatres, catheterisation laboratories, and advanced diagnostic imaging, built around five specialities (cardiology, oncology, neurology, gastroenterology-hepatology, orthopaedics) that account for much of the treatment Indonesians travel abroad for. The hospital opened in June 2025 with services phased in, normal for a tertiary facility still ramping its programmes in its first years.
Sixteen facilities, not one hospital
BIH is the anchor, not the whole zone. KEK Sanur covers 41.26 hectares under InJourney, the state tourism holding operating under Indonesia’s Danantara sovereign wealth fund. InJourney has cited sixteen health facilities across the zone: ten independent international clinics, with partners reported from South Korea, Turkey, Malaysia, Germany, and Japan, plus six specialty service centres run by BIH itself.
Read those numbers soberly: agreements are a pipeline, not a completed skyline, and some will lapse or change shape before opening. Watch bed occupancy, international patient counts, and whether these sixteen commitments actually convert into opened doors, not the headline that announced them.
Why the credibility layer is the whole argument
KEK Sanur exists because Indonesians spend heavily on healthcare abroad: around two million citizens travel overseas for treatment yearly, with spending estimated between roughly US$9 billion and US$11.5 billion. Credibility is the binding constraint: patients who fly to Singapore or Kuala Lumpur trust the institution, not the flight. The Mayo layer addresses standards, the 2023 Health Law’s foreign-specialist provisions address capability, and SEZ incentives address operator economics. Whether the stack works will show in occupancy and patient counts over the next several years, not in press releases.
What this means for surrounding asset values
Functioning medical destinations generate demand beyond the hospital gate: accommodation, recovery lodging, diagnostics, pharmacies, transport, and food service cluster around patient flows. Sanur sits inside an established beachfront resort area, so hospitality fabric already exists and is repricing. Asking prices in Sanur’s core corridors have climbed since 2022, but transaction data in Bali is thin, and a credibility thesis can take years to convert into patient volume. The SEZ has shifted demand from tourism-cyclical to partly healthcare-driven, supporting values without guaranteeing them. Our running overview of investment opportunities around KEK Sanur tracks which asset categories that shift favours.
Due diligence before you commit
For foreign investors, entry mechanics deserve as much attention as the thesis. Clinical businesses require licensing separate from company formation; a PT PMA structure, zoning confirmation, and SEZ eligibility each involve their own verification steps in a regulated sector where shortcuts are expensive. Our medical tourism business entry advisory maps realistic entry routes, from clinic partnerships to supporting-services businesses, and coordinates introductions through the group’s operating network, active in Bali since 2015. We are an advisory and curation desk, not a hospital operator, and say so plainly.
It helps to see the patient side of the ecosystem first-hand before investing in it. Families already use private medical concierge services in Bali to coordinate appointments, transport, and recovery stays end-to-end, a preview of the service economy the SEZ is designed to grow.
This guide is general information, not financial or legal advice. Verify current regulations with licensed advisors.
If you are weighing an entry around KEK Sanur and want the confirmed picture rather than the brochure version, talk to our desk on WhatsApp +62 811-3941-4563 or email bd@juaraholding.com. We will tell you what is verified, what is pipeline, and what is marketing, in that order.